AKB-9785

N/A

Report date: 2025/04/09 16:00:49
NME

Base Information

Drug NameAKB-9785
Drug Alias NameAKB-9785
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionReceptor-type tyrosine-protein phosphatase beta inhibitors
TargetsReceptor-type tyrosine-protein phosphatase beta
Therapy Area/IndicationsLung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAerpio Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesAadi Subsidiary Inc
Inactive CompaniesAerpio Therapeutics Llc
Active IndicationsLung Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A